Home/CFR/Title 21/Part 314/§ 314.70314.70
FEDERAL · 21 CFR

§ 314.70314.70 — Not Yet Available

21 C.F.R. § 314.70314.70

21 C.F.R. § 314.70314.70 is referenced in other legal documents but could not be loaded from the eCFR.

This section may have been removed, reserved, or renumbered. Browse Part 314 or Title 21 — Food and Drugs for available sections.

Nearby Sections

15
§ 314.1
Scope of this part.
§ 314.2
Purpose.
§ 314.3
Definitions.
§ 314.50
Content and format of an NDA.
§ 314.52
Notice of certification of invalidity, unenforceability, or noninfringement of a patent.
§ 314.53
Submission of patent information.
§ 314.54
Procedure for submission of a 505(b)(2) application requiring investigations for approval of a new indication for, or other change from, a listed drug.
§ 314.55
Pediatric use information.
§ 314.56
Nonprescription drug product with an additional condition for nonprescription use (ACNU).
§ 314.60
Amendments to an unapproved NDA, supplement, or resubmission.
§ 314.65
Withdrawal by the applicant of an unapproved application.
§ 314.70
Supplements and other changes to an approved NDA.
§ 314.71
Procedures for submission of a supplement to an approved application.
§ 314.72
Change in ownership of an application.
§ 314.80
Postmarketing reporting of adverse drug experiences.